These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38627865)

  • 1. Characterizing glucokinase variant mechanisms using a multiplexed abundance assay.
    Gersing S; Schulze TK; Cagiada M; Stein A; Roth FP; Lindorff-Larsen K; Hartmann-Petersen R
    Genome Biol; 2024 Apr; 25(1):98. PubMed ID: 38627865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing glucokinase variant mechanisms using a multiplexed abundance assay.
    Gersing S; Schulze TK; Cagiada M; Stein A; Roth FP; Lindorff-Larsen K; Hartmann-Petersen R
    bioRxiv; 2023 May; ():. PubMed ID: 37292969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive map of human glucokinase variant activity.
    Gersing S; Cagiada M; Gebbia M; Gjesing AP; Coté AG; Seesankar G; Li R; Tabet D; Weile J; Stein A; Gloyn AL; Hansen T; Roth FP; Lindorff-Larsen K; Hartmann-Petersen R
    Genome Biol; 2023 Apr; 24(1):97. PubMed ID: 37101203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
    Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
    Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase.
    Gutierrez-Nogués A; García-Herrero CM; Oriola J; Vincent O; Navas MA
    Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2385-2394. PubMed ID: 29704611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).
    George DC; Chakraborty C; Haneef SA; Nagasundaram N; Chen L; Zhu H
    Theranostics; 2014; 4(4):366-85. PubMed ID: 24578721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and bioinformatics analysis of four novel GCK missense variants detected in Caucasian families with GCK-MODY phenotype.
    Costantini S; Malerba G; Contreas G; Corradi M; Marin Vargas SP; Giorgetti A; Maffeis C
    Clin Genet; 2015 May; 87(5):440-7. PubMed ID: 24735133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
    Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
    Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
    J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
    Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
    PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase.
    Larion M; Salinas RK; Bruschweiler-Li L; Miller BG; Brüschweiler R
    PLoS Biol; 2012; 10(12):e1001452. PubMed ID: 23271955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of connecting loop I in catalysis and allosteric regulation of human glucokinase.
    Martinez JA; Larion M; Conejo MS; Porter CM; Miller BG
    Protein Sci; 2014 Jul; 23(7):915-22. PubMed ID: 24723372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
    Shen Y; Cai M; Liang H; Wang H; Weng J
    Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
    Beer NL; van de Bunt M; Colclough K; Lukacs C; Arundel P; Chik CL; Grimsby J; Ellard S; Gloyn AL
    J Biol Chem; 2011 May; 286(21):19118-26. PubMed ID: 21454522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.